The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.

The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era. Biol Blood Marrow Transplant. 2020 06; 26(6):1137-1143.

View in: PubMed

subject areas

Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cell Transplantation
Humans
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Lymphocyte Transfusion
Lymphocyte Transfusion
Lymphocytes
Lymphocytes
Protein Kinase Inhibitors
Protein Kinase Inhibitors
Recurrence
Recurrence
Retrospective Studies
Retrospective Studies

authors with profiles

Jennifer L Holter Chakrabarty